Evidence map›Paper›PMID 34069191›Full record

ArticleCancers2021

Reduced Lamin A/C Does Not Facilitate Cancer Cell Transendothelial Migration but Compromises Lung Metastasis.

Francesco Roncato, Ofer Regev, Sara W Feigelson, Sandeep Kumar Yadav, Lukasz Kaczmarczyk, Nehora Levi, Diana Drago-Garcia, Samuel Ovadia, Marina Kizner, Yoseph Addadi and 6 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Nuclear destabilisation - a possible genesis of cancer?Biological reviews of the Cambridge Philosophical Society · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Francesco RoncatoDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0002-3425-4135
Ofer RegevDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Sara W FeigelsonDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Sandeep Kumar YadavDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-6999-040X
Lukasz KaczmarczykDepartment of Molecular Biology, Ariel University, Kiryat Hamada, Ariel 40700, Israel.ORCID 0000-0001-5703-4525
Nehora LeviDepartment of Molecular Biology, Ariel University, Kiryat Hamada, Ariel 40700, Israel.
Diana Drago-GarciaDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-6397-3123
Samuel OvadiaDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Marina KiznerDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.
Yoseph AddadiLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-9827-0436
João C SabinoInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0001-7991-4291
Yossi OvadyaDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Sérgio F de AlmeidaInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0002-7774-1355
Ester FeldmesserLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0002-7017-4861
Gabi GerlitzDepartment of Molecular Biology, Ariel University, Kiryat Hamada, Ariel 40700, Israel.ORCID 0000-0001-6422-8715
Ronen AlonDepartment of Immunology, Weizmann Institute of Science, Rehovot 76100, Israel.

Funding

German-Israeli Foundation I-1470-412.13/2018Helen and Martin Kimmel Institute for Stem Cell Research n.Horizon 2020 Framework Programme 857119Israel Cancer Association USA 20201181Israel Science Foundation 791/17Meyer Henri Cancer Endowment n.Moross Integrated Cancer Center n.the Minerva Stiftung n.William and Marika Glied and Carol A. Milett n.Yeda-Sela Center for Basic Research n.
6 · The paper itself

Abstract

The mechanisms by which the nuclear lamina of tumor cells influences tumor growth and migration are highly disputed. Lamin A and its variant lamin C are key lamina proteins that control nucleus stiffness and chromatin conformation. Downregulation of lamin A/C in two prototypic metastatic lines, B16F10 melanoma and E0771 breast carcinoma, facilitated cell squeezing through rigid pores, and reduced heterochromatin content. Surprisingly, both lamin A/C knockdown cells grew poorly in 3D spheroids within soft agar, and lamin A/C deficient cells derived from spheroids transcribed lower levels of the growth regulator

Indexed as

cancer metastasischemotaxisdiapedesisepigeneticsextravasationimagingnucleus

Identifiers

PMID34069191
PMCPMC8157058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.